A study found that both rosiglitazone (p = 0.026) and pioglitazone (p = 0.004) groups with T2DM exhibited a significant increase in adiponectin levels compared to the placebo group, resulting in decreased TG concentration [43]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.